Selective delivery of doxorubicin using the biomarker-specific, aptamer-functionalized DNA nanosphere
Authors:
- Supattra ChaithongyotSCSupattra Chaithongyot
- Ratchanee DuangratRDRatchanee Duangrat
- Chanida WootthichairangsanCWChanida Wootthichairangsan
- Rattanavinan HanchainaRHRattanavinan Hanchaina
- Anuttara UdomprasertAUAnuttara Udomprasert
- Thaned KangsamaksinTKThaned Kangsamaksin
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Materials Letters
- Vol. 260
Abstract
No abstract availableKeywords
Funding Information
- Thailand Research Fund
- Faculty of Science, Mahidol University
This publication has 22 references indexed in Scilit:
- Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagyBiochemical Journal, 2016
- Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitroOncotarget, 2016
- Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome AcidificationCirculation, 2016
- Intracellular Delivery of a Planar DNA Origami Structure by the Transferrin‐Receptor Internalization PathwaySmall, 2016
- Facile and Scalable Preparation of Pure and Dense DNA Origami SolutionsAngewandte Chemie International Edition, 2014
- DNA Origami as a Carrier for Circumvention of Drug ResistanceJournal of the American Chemical Society, 2012
- PEGylation and Biodistribution of an anti-MUC1 Aptamer in MCF-7 Tumor-Bearing MiceBioconjugate Chemistry, 2012
- Aptamer-Conjugated DNA Icosahedral Nanoparticles As a Carrier of Doxorubicin for Cancer TherapyACS Nano, 2011
- Doxorubicin pathwaysPharmacogenetics and Genomics, 2011
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990